ACET Q1 2023 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$33M

Net Income

-$31M

EPS (Diluted)

$-11.04

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$26M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$305M

Total Liabilities

$39M

Stockholders' Equity

$266M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$25M	-100.0%
Gross Profit	$0	$25M	-100.0%
Operating Income	-$33M	$5M	-808.1%
Net Income	-$31M	$5M	-768.7%